<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Telavancin</id>
	<title>Telavancin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Telavancin"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Telavancin&amp;action=history"/>
	<updated>2026-04-27T01:44:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Telavancin&amp;diff=5369020&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Telavancin&amp;diff=5369020&amp;oldid=prev"/>
		<updated>2024-03-06T04:44:41Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Telavancin.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Telavancin&amp;#039;&amp;#039;&amp;#039; is a [[lipoglycopeptide]] [[antibiotic]] used in the treatment of certain [[bacterial infections]]. It is a semi-synthetic derivative of [[vancomycin]], and was approved by the [[Food and Drug Administration|FDA]] in 2009.&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
Telavancin inhibits [[cell wall]] synthesis in bacteria by binding to the [[D-alanyl-D-alanine]] terminus of the cell wall precursor [[lipid II]]. This prevents the incorporation of lipid II into the growing bacterial cell wall, leading to cell death. Telavancin also disrupts bacterial cell membrane function, which contributes to its bactericidal activity.&lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
Telavancin is indicated for the treatment of [[skin and skin structure infections]] caused by susceptible [[Gram-positive bacteria]], including [[methicillin-resistant Staphylococcus aureus|MRSA]]. It is also used in the treatment of [[hospital-acquired pneumonia]] and [[ventilator-associated pneumonia]] caused by Staphylococcus aureus, including MRSA.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Common side effects of telavancin include [[nausea]], [[vomiting]], and [[diarrhea]]. Serious side effects can include [[kidney damage]], [[QT interval]] prolongation, and [[Clostridium difficile]] infection.&lt;br /&gt;
&lt;br /&gt;
==Pharmacokinetics==&lt;br /&gt;
Telavancin is administered intravenously. It has a half-life of approximately 8 hours and is primarily excreted in the urine.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Vancomycin]]&lt;br /&gt;
* [[Lipoglycopeptide]]&lt;br /&gt;
* [[Antibiotic]]&lt;br /&gt;
* [[Methicillin-resistant Staphylococcus aureus|MRSA]]&lt;br /&gt;
* [[Hospital-acquired pneumonia]]&lt;br /&gt;
* [[Ventilator-associated pneumonia]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Antibiotics]]&lt;br /&gt;
[[Category:Lipoglycopeptides]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
&lt;br /&gt;
{{Pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>